PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Condition: Pancreatic Cancer Interventions: Drug: Trametinib; Drug: Hydroxychloroquine Sponsors: Cancer Trials Ireland; Novartis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hydroxychloroquine | Ireland Health | Pancreas | Pancreatic Cancer | Research | Study